FarmavitaR+

regulatory affairs network

  • Increase font size
  • Default font size
  • Decrease font size

Understanding USP 71 Sterility Tests and Extended BUD

E-mail Print PDF

One of the most frequently asked questions recently asks how to extend the Beyond-Use Date (BUD) of compounded sterile preparations (CSPs). Eric S. Kastango, RPh, MBA, FASHP, reviewed the requirements of USP Chapter 797 necessary to complete in order to extend BUD. The use and limitation of sterility tests according to USP 71 was reviewed, along with process verification.

Click here for recorded webinar.

 
Banner


Login With Facebook

Regulatory Network

Members : 964
Content : 235
Web Links : 5
Content View Hits : 653919

Who's Online

We have 137 guests online

Featured Partners

Regulanet - regulatory affairs consortium

regulanet®: Local representation for Global Regulatory Affairs

 

Tarius - Regulatory Intelligence Databases

Farmavita.Net - pharmaceutical lisensing network

Pharmaceutical Licensing and technology transfer

 

Authnetic and secured web site

 

Increase your website traffic with Attracta.com


Featured Event

Famavita_150x150_mobile_pharma

Featured Event

bals115_150x150

Featured Event

KSLS08_150x150


Active Groups

{captcha}